CEFEPIME FOR INJECTION POWDER FOR SOLUTION

দেশ: কানাডা

ভাষা: ইংরেজি

সূত্র: Health Canada

সক্রিয় উপাদান:

CEFEPIME (CEFEPIME HYDROCHLORIDE)

থেকে পাওয়া:

APOTEX INC

এটিসি কোড:

J01DE01

INN (আন্তর্জাতিক নাম):

CEFEPIME

ডোজ:

1G

ফার্মাসিউটিকাল ফর্ম:

POWDER FOR SOLUTION

রচনা:

CEFEPIME (CEFEPIME HYDROCHLORIDE) 1G

প্রশাসন রুট:

INTRAMUSCULAR

প্যাকেজ ইউনিট:

IM:2.4ML/ IV:10ML/ IV INF:SEE PM.

প্রেসক্রিপশন টাইপ:

Prescription

থেরাপিউটিক এলাকা:

FOURTH GENERATION CEPHALOSPORINS

পণ্য সারাংশ:

Active ingredient group (AIG) number: 0150504004; AHFS:

অনুমোদন অবস্থা:

APPROVED

অনুমোদন তারিখ:

2009-02-16

পণ্য বৈশিষ্ট্য

PRODUCT MONOGRAPH
Cefepime for Injection
(cefepime hydrochloride)
1 g and 2 g cefepime per vial
Orchid Standard
Antibiotic
_Manufactured by: _
ORCHID HEALTHCARE
(A Division of Orchid Chemicals & Pharmaceuticals Ltd.)
Plot No: B3-B6 & B11-B14, SIPCOT Industrial Park,
Irungattukottai- 602 105, Sriperumbudur P.O.,
Kancheepuram District, INDIA.
_Manufactured for: _
APOTEX INC.
150 Signet Drive
Weston, ON, M9L 1T9
DATE OF PREPARATION
April 20, 2020
Control #: 234594
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.................................................. 3
SUMMARY PRODUCT INFORMATION
.............................................................................
3
INDICATIONS AND CLINICAL
USE...................................................................................
3
CONTRAINDICATIONS
........................................................................................................
5
WARNINGS AND PRECAUTIONS
......................................................................................
5
ADVERSE REACTIONS
........................................................................................................
8
DRUG INTERACTIONS
.......................................................................................................
10
DOSAGE AND ADMINISTRATION
...................................................................................
10
OVERDOSAGE
.....................................................................................................................
15
ACTION AND CLINICAL PHARMACOLOGY
................................................................. 15
STORAGE AND STABILITY
..............................................................................................
19
SPECIAL HANDLING INSTRUCTIONS
............................................................................
19
DOSAGE FORMS, COMPOSITION AND PACKAGING
.................................................. 19
PART II: SCIENTIFIC INFORMATION
.........................................................